Literature DB >> 28503276

Do statins adversely affect the HbA1c of diabetic patients?

W D Son1, C L Teng2.   

Abstract

This paper discusses the adverse effect of statins on the HbA1c levels of diabetic patients. Studies have shown that statins may slightly worsen the HbA1c level. The effects vary depending on the type of statins, the dosage and the duration of therapy. However, it has been confirmed that statin use has benefits that outweigh its harms. Therefore, a diabetic patient should be given advice on the need for appropriate lifestyle changes and the importance of continuing the statins.

Entities:  

Keywords:  Type 2 diabetes mellitus; haemoglobin A1c; hydroxymethylglutaryl-CoA reductase inhibitors

Year:  2017        PMID: 28503276      PMCID: PMC5420325     

Source DB:  PubMed          Journal:  Malays Fam Physician        ISSN: 1985-2274


  6 in total

1.  Effects of rosuvastatin and atorvastatin on glycaemic control in Type 2 diabetes---the CORALL study.

Authors:  S Simsek; C G Schalkwijk; B H R Wolffenbuttel
Journal:  Diabet Med       Date:  2012-05       Impact factor: 4.359

Review 2.  Statins for primary prevention of cardiovascular and cerebrovascular events in diabetic patients without established cardiovascular diseases: a meta-analysis.

Authors:  Y-H Chen; B Feng; Z-W Chen
Journal:  Exp Clin Endocrinol Diabetes       Date:  2011-12-20       Impact factor: 2.949

3.  Differences between rosuvastatin and atorvastatin in lipid-lowering action and effect on glucose metabolism in Japanese hypercholesterolemic patients with concurrent diabetes. Lipid-lowering with highly potent statins in hyperlipidemia with type 2 diabetes patients (LISTEN) study –.

Authors:  Hisao Ogawa; Kunihiko Matsui; Yoshihiko Saito; Seigo Sugiyama; Hideaki Jinnouchi; Masahiro Sugawara; Izuru Masuda; Hisao Mori; Masako Waki; Minoru Yoshiyama; Hirotaka Watada
Journal:  Circ J       Date:  2014-09-02       Impact factor: 2.993

4.  Statin therapy on glycaemic control in type 2 diabetes: a meta-analysis.

Authors:  Yi Zhou; Yang Yuan; Rong-Rong Cai; Yan Huang; Wen-Qing Xia; Yue Yang; Pin Wang; Qiong Wei; Shao-Hua Wang
Journal:  Expert Opin Pharmacother       Date:  2013-07-05       Impact factor: 3.889

5.  Statin therapy and risk of developing type 2 diabetes: a meta-analysis.

Authors:  Swapnil N Rajpathak; Dharam J Kumbhani; Jill Crandall; Nir Barzilai; Michael Alderman; Paul M Ridker
Journal:  Diabetes Care       Date:  2009-10       Impact factor: 19.112

Review 6.  Statins and glycaemic control in individuals with diabetes: a systematic review and meta-analysis.

Authors:  Sebhat Erqou; C Christine Lee; Amanda I Adler
Journal:  Diabetologia       Date:  2014-09-23       Impact factor: 10.122

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.